Johnson & Johnson Subsidiary Loses First Levaquin Lawsuit

On Wednesday, a Minneapolis jury ordered Johnson & Johnson subsidiary Ortho-McNeil-Janssen Pharmaceuticals to pay an 87-year-old man $1.7 million because its antibiotic Levaquin damaged his Achilles tendons. It was the first ve…

Johnson & Johnson Launches Offer for Crucell

As part of its efforts to expand into the biotech market, Johnson & Johnson is making a long-anticipated bid for Dutch vaccine maker Crucell — in spite of Crucell’s recent manufacturing troubles.
Continue read…